Aspira Women's Health Inc... (AWH)
0.23
-0.01 (-4.25%)
At close: Feb 20, 2025, 3:59 PM
0.23
0.58%
After-hours: Feb 20, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 0.23 |
| Market Cap | 3.99M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.15 |
| PE Ratio (ttm) | -0.2 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 0.24 |
| Volume | 174,069 |
| Avg. Volume (20D) | 155,318 |
| Open | 0.25 |
| Previous Close | 0.24 |
| Day's Range | 0.23 - 0.25 |
| 52-Week Range | 0.21 - 4.72 |
| Beta | undefined |
About AWH
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service fo...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Oct 2, 2000
Employees 64
Stock Exchange NASDAQ
Ticker Symbol AWH
Website https://aspirawh.com
Analyst Forecast
According to 2 analyst ratings, the average rating for AWH stock is "Buy." The 12-month stock price forecast is $4.4, which is an increase of 1849.49% from the latest price.
Buy 50.00%
Hold 50.00%
Sell 0.00%
Next Earnings Release
Aspira Women's Health Inc. is scheduled to release its earnings on Mar 27, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
7 months ago
+7.63%
Aspira Women's Health shares are trading higher af...
Unlock content with
Pro Subscription
7 months ago
+4.04%
Aspira Women's Health shares are trading higher. The company announced a private placement equity financing of $1.935 million.
